CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Grant or award Director acquired 99,483 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 56,818 shares (grant or award)
- 4 Grant or award Director acquired 56,818 shares (grant or award)
- 4 Grant or award Director acquired 68,182 shares (grant or award)
- 4 Grant or award Director acquired 56,818 shares (grant or award)
- 4 Grant or award Vice President of Operations acquired 185,748 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO acquired 65,376 shares (grant or award)
- 4 Grant or award Medical Director acquired 20,067 shares (grant or award)
- 4 Grant or award CFO acquired 18,015 shares (grant or award)
- 4 Grant or award Medical Director acquired 43,962 shares (grant or award)
- 4 Grant or award CEO acquired 154,527 shares (grant or award)
- 4 Grant or award CFO acquired 37,791 shares (grant or award)
- 4 Grant or award CEO acquired 192,870 shares (grant or award)
- 4 Grant or award Medical Director acquired 54,015 shares (grant or award)
- 4 Grant or award CFO acquired 47,118 shares (grant or award)
- 4 Grant or award CEO acquired 405,909 shares (grant or award)
- 4 Grant or award Medical Director acquired 112,542 shares (grant or award)
- 4 Grant or award Director acquired 508,528 shares (grant or award)
Page 24 of 31 · 616 filings